Neuphoria Therapeutics Inc. NEUP
3.65
0.00
0.00%
as of 25 Sep
- Market cap
- $19.8M
- P/E
- 0.0×
Follow NEUP
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
27.33 | 13.91 | 9.03 | 2.68 | |
Current Ratio |
27.85 | 14.31 | 9.04 | 2.72 | |
Net Debt/EBITDA |
3.04 | 18.59 | 5.71 | 2.50 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.25) | 6.61 | (3.45) | 0.38 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.27 | 0.38 | 0.36 | 0.49 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
0.28 | (0.62) | (1.42) | (1.69) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.28 | (0.62) | (1.42) | (1.69) | |
Cash per Share |
4.52 | 3.59 | 4.91 | 6.11 | |
Shareholders Equity per Share |
5.60 | 5.44 | 6.55 | 5.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.60 | 5.44 | 6.55 | 5.57 | |
Free Cash Flow |
1.21 | (3.34) | (6.44) | (3.79) | |
Working Capital |
20.31 | 20.14 | 20.80 | 8.83 | |
Net Current Asset Value |
16.96 | 16.27 | 16.49 | (0.88) | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.41 | 0.81 | 0.57 | 0.06 | |
Average Payables |
0.77 | 0.69 | 1.03 | 1.35 | |
Average Assets |
28.65 | 32.76 | 27.38 | 25.13 | |
Average Common Equity |
21.80 | 27.71 | 21.72 | 14.79 |
Columns are period end dates · fundamentals updated 23 Sep 2026